A Clinical Trial Trial of Gemcitabine in Children With Newly-Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG)
Latest Information Update: 07 Mar 2024
At a glance
- Drugs Gemcitabine (Primary)
- Indications Diffuse intrinsic pontine glioma; Glioma
- Focus Pharmacokinetics
- 01 Mar 2024 Status changed from recruiting to active, no longer recruiting.
- 16 Feb 2023 Planned End Date changed from 1 Dec 2023 to 1 Dec 2025.
- 16 Feb 2023 Planned primary completion date changed from 1 Dec 2022 to 1 Dec 2024.